Wire · regulatory
Sanofi to stop disparaging rival flu vaccine to stave off EU antitrust fine
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 8 July 2026 · Fusion42 review
Sanofi has offered commitments to EU antitrust regulators to stop disparaging rival flu vaccine Fluad, including public statements affirming equal efficacy and refraining from negative comparisons for two years across Germany and France. The move preempts potential fines up to 10% of global turnover for alleged anti-competitive conduct.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
EU antitrust enforcement against disparagement tactics in pharma is escalating; founders in regulated life sciences must audit comparative claims and marketing practices to avoid 10% revenue fines.
◆ Coverage
1 source · 8 Jul 2026
◆ Related on Wire
◆ Topics